News/ColumnsScott Graham, The National Law Journal
Appeals Court Stays Injunction in Sanofi-Amgen Patent Fight
The U.S. Court of Appeals for the Federal Circuit hit pause Wednesday on a Delaware judge's order that would block sales of Sanofi's cholesterol drug Praluent.
This premium content is reserved for Delaware Law Weekly subscribers.
Continue reading by getting started with a subscription.
Already a subscriber? Log in now